A phase 2 study of allogeneic mesenchymal stromal cells for luminal crohn's disease refractory to biologic therapy

Geoffrey Forbes, Marian Sturm, R. Leong, M.P. Sparrow, D.S. Segarajasingam, A.G. Cummins, Michael Phillips, Richard Herrmann

Research output: Contribution to journalArticlepeer-review

276 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase 2 study of allogeneic mesenchymal stromal cells for luminal crohn's disease refractory to biologic therapy'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Veterinary Science and Veterinary Medicine